Illumina Inc.
- ILMN
- NASDAQ
- Consumer Products
- Latest 71.01
- Currency US$
- Change 0.32
- Percent Change 0.453 %
- Volume 1,187,868
- Thu May 23, 2013 3:13 PM EDT NASDAQ data delayed 15 minutes.
The Globe and Mail
- Open 69.48
- Previous Close 70.69
- High 71.20
- Low 67.90
- Bidx1 71.01
- Askx1 71.02
- 52-week High 05/10 77.11
- 52-week Low 06/08 37.77
- Beta 0.934
- Market Cap 8,808.08M
- EPS 1.06
- P/E 67.00
- Forward P/E 36.046
- PEG 2.50
- Annual Dividend --
- Yield --
News
- Illumina Launches BaseSpace® Apps
- Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation Kits
- Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May
- Verinata Health Publishes Clinical Laboratory Performance Data for verifi® Prenatal Test
- Illumina Names Charles Dadswell as Senior Vice President and General Counsel
Financials & Calendars
- Sales $1,206,710,000
- Earnings $102,460,000
- Return on Equity 7.79%
- Cash Flow --
- Cash $443,080,000
- Current Ratio 3.78
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $2,744,180,000
- Liabilities $1,432,360,000
- Liabilities-to-Equity Ratio 1.09
Price Ratios
- Price to Sales 7.30
- Price to Book 6.71
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 22 | $0.38 | Jul 23 | $0.39 |
| Surprises | Apr 22 | 21.05% | n/a | n/a |
| Dividends | n/a | n/a | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 23, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.
Officers
- WILLIAM H. RASTETTER Chairman
- JAY T. FLATLEY President; C.E.O & Director
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Head Office
5200 ILLUMINA WAYSAN DIEGO, CA
92122
Phone: 8582024500
Fax: (858)-2024766
Ideas & Discussion
Live Discussion of ILMN on StockTwits